Comments for BCR - Stockpickr! Your Source for Stock Ideas

Comments for BCR

Added By	Comments	Type	Date Added
barrons3	Finerman said she would stick with low-tech medical device companies that sell things that hospitals need. She liked companies like CR Bard (BCR) and Becton, Dickinson (BDX) that are trading a lot lower than their average multiple over the past five years. "They're winners regardless of the outcome," she said.	Love	November 25, 2009
RhinoStocks	This medical device maker has a history of beating analyst expectations and garnering acclaim from Wall Street.	Love	November 16, 2009
High Dividends	increased by 6 percent to 17 cents per share, payable on July 31, 2009 to shareholders of record at the close of business on July 20, 2009.	Love	June 13, 2009
Trading Nymph	7:30	Love	December 30, 2008
barrons3	C.R' Bard, which makes medical, surgical, diagnostic and patient-care products from catheters to IV systems, also looks solid. "They have more than 10,000 products, but there is no single product they will either live or die by," says Willey, who describes the company's products as "mid-tech." "These aren't heart-replacement or cardiac implants," he says. "The vast majority of what they sell is not part of the hospital's capital budget; [it's] part of the operating budget, and that's a good thing in this environment." Bard earned $1.09 a share in the third quarter, versus 96 cents a share 12 months earlier, on net sales of nearly $617 million -- up 13%. Its international business, currently about 32% of sales, is growing. And two of its largest sales categories, vascular and oncology, each posted 20% growth in net sales. Offerings include stents and catheters as well as biopsy products. The shares trade at about 15 times the $5.06 analysts expect Bard to earn next year, below its median forward price/earnings ratio of 21.5.	Love	November 22, 2008
barrons2	But for those who think that the decline in commodities is signaling total collapse of the economies, then these will work. Schering-Plough (SGP)? I don't know ... I like Gilead (GILD), which is on fire. Abbott (ABT) had a great quarter. Bard (BCR) and Becton (BDX)? The latter, thought of as a resin play, seems particularly good for the moment.	Love	August 07, 2008
barrons2	You can do one of two things: You can attempt to have a longer-term view on the stocks that are doubling and halving, or you can steer clear of all of the nonsense and find the General Mills (GIS) and the C.R. Bards (BCR), the Celgenes (CELG) and the Becton Dickinsons (BDX).	Love	July 31, 2008
High Dividends	7%	Love	June 16, 2008
irish5	Good medical company	Love	February 16, 2008
barrons2	On Thursday we've got C.R. Bard (BCR), the bard, a Cramer fave that could end the winter of our discontent, as well as Becton (BDX). They're two medical device stocks. I like 'em both, and want to buy on any weakness.	Love	January 24, 2008
sarah z	C.R. Bard Inc. said Wednesday it authorized the repurchase of up to $500 million of its common stock. The medical technologies developer trades for 14x cash flow.	Love	October 24, 2007
sarah z	C.R. Bard Inc. said Wednesday it authorized the repurchase of up to $500 million of its common stock. The medical technologies developer trades for 14x cash flow.	Love	October 17, 2007
skiman14	Always delivers growth; disposable products create revolving market of buyers	Love	June 28, 2007
eattherich	mentions: 3	Love	May 30, 2007
bhubb	80% of kindey business	Love	May 03, 2007
VaBthang4	Medical Industrial Complex	Love	May 02, 2007
Guest	The first 'B' name is CR Bard (BCR), Cramer said. Although the stock is up 25% since he first suggested buying it in September 2005, Cramer believes Bard should continue on its pathway up. Bard, Cramer said, is a "primo" medical device maker. Last year, 80% of its sales came from markets where it ranks No. 1 or No. 2 in market share. In 2005, Cramer advised buying Bard as a takeover target, and on Monday Cramer recommended it the same way, saying the company is small enough to swallow. No matter what happens to the economic climate, Bard will not be affected, because it makes medical devices that people cannot live without. Bard is also sitting on half a billion dollars in cash, which it can use to increase its dividend or purchase companies of its own, he said.	Love	May 01, 2007
purduerph	mad money 4/30/07	Love	May 01, 2007